82 results
Page 2 of 5
8-K
EX-2.1
4sfmy5 embh
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
EX-99.1
gshpcb2q0je
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
kpybbu3t lkt0
21 Dec 20
Regulation FD Disclosure
7:04am
S-3ASR
EX-4.4
qyddri0vavn77gzw3w2
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-4.5
91459w
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-1.2
b55m2eza7je2d87g mz1
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-99.1
420l1q
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-1.1
hdsrqjtq5fifm30u4
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm